ASCAP, BMI, SoundExchange, and the Mechanical Licensing Collective changed the music industry by making rights administration scale. DAORX is designed to do the same for healthcare data.

The Underclaim Problem

U.S. healthcare data is generated continuously — every clinical encounter, every lab result, every medication response, every wearable telemetry stream. The data is licensed extensively to pharmaceutical companies for drug development, to insurers for actuarial models, to AI organizations for model training, to academic researchers for studies, and to public health agencies for population analysis.

The market value of these data flows is, by various estimates, in the tens of billions of dollars annually. Almost none of that value flows back to the patients whose biology produced the data, or to the providers whose longitudinal care produced the outcomes. The result is structurally extractive: the data subjects pay full price for the drugs, devices, and services that their own data made possible, while data brokers and intermediaries capture the value in between.

DAORX is designed to redirect that value flow through the same architectural mechanism the music industry uses to redirect performance, mechanical, sync, and master use royalties: a rights administration organization, operating at scale, with cryptographic identification of rights holders and automated distribution of royalties per pre-registered splits.

The Music Industry Analogy

Music’s rights administration system has eight functional components. Each maps directly to a healthcare data analog:

Eight Monetization Modes

Streaming royalties

Per-query micro-royalty when authorized parties access categorized data — the per-stream analog. Volume-based, automated, transparent.

Sync licensing

Higher-rate licensing for bounded, named, discrete uses such as a specific pharmaceutical cohort study. The film-and-TV-music analog.

Mechanical rights

Royalties when the rights holder’s data contributes to a downstream commercial product — an FDA-approved therapy, a deployed clinical AI model, a commercial study. The publishing analog.

Performance royalties

Continuous royalties for live telemetry streams subscribed to by digital health platforms, remote monitoring services, or quality reporting programs. The live broadcast analog.

Sample clearance

Per-record fees when data is used in AI training, plus ongoing royalties when models trained on the data are commercialized. The hip-hop sample analog.

Exclusive licensing

Rights holders with rare or strategically valuable data may grant exclusive licenses for defined terms at premium pricing. The master recording exclusive analog.

Catalog assignment

Rights holders may assign future royalty streams to a buyer for a lump sum, or pass the rights instrument to heirs as part of an estate. The music catalog acquisition analog.

Contributor splits

Provider participants serve as co-contributors to patient outcome data and earn proportional royalties on licensed access. The songwriter-collaboration analog.

The Administration Fee

DAORX retains a nominal administration fee on each licensed access event. The fee is analogous to the rights administration fee retained by music collection societies — typically a small percentage of the royalty, with the substantial majority of the value remitted to the rights holder. The administration fee compensates the rail for operating the metering, calculation, distribution, and audit trail infrastructure that makes the rights administration system work.

DAORX does not take custody of the licensed payment. The smart contract routes payment directly from the licensee to the rights holder, with the administration fee deducted at the moment of routing. DAORX is a conduit, not a custodian.